Bioage Labs Announces Discontinuation Of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag In Combination With Tirzepatide For The Treatment Of Obesity
Bioage Labs Announces Discontinuation Of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag In Combination With Tirzepatide For The Treatment Of Obesity . (MENAFN - GlobeNewsWire - Nasdaq) Decision follows observations of liver transaminitis without clinically significant symptoms in some subjects on azelaprag Company will evaluate data from patients ...
América - MenaFN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108965778/Bioage-Labs-Announces-Discontinuation-Of-STRIDES-Phase-2-Clinical-Trial-Evaluating-Azelaprag-In-Combination-With-Tirzepatide-For-The-Treatment-Of-Obesity
2024-12-06
rss
(MENAFN - GlobeNewsWire - Nasdaq) Decision follows observations of liver transaminitis without clinically significant symptoms in some subjects on azelaprag Company will evaluate data from patients ...
Bioage Labs Announces Discontinuation Of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag In Combination With Tirzepatide For The Treatment Of Obesity